Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

July 1998

Are Pathologists The Next ā€œFish In The Barrel?ā€

Commentary and Opinion by R. Lewis Dark /

ā€œSHOOTING FISH IN THE BARRELā€ MAY BE A GOOD METAPHOR TO DESCRIBE what can soon happen to the profession of pathology. This issue of THE DARK REPORT covers several important stories on laboratory management, with direct consequences to pathologists. First, the ISO 9001 certification of the Nichols Institute division of Quest Diagnostics Incorporated (see pages […]

To access this post, you must purchase The Dark Report.

Are Pathologists The Next ā€œFish In The Barrel?ā€ Read More Ā»

Nichols Institute Earns ISO 9001 Certification

Laboratory Management /

CEO SUMMARY: Although itā€™s the first ISO 9001-certified clinical laboratory in North America, Quest Diagnosticsā€™ Nichols Institute is a late-comer to the party. Most major diagnostics companies already have ISO 9001 certification. This issue of THE DARK REPORT explores why Nicholsā€™ ISO certification is an industry milestone. Our prediction is that all larger laboratory organizations

To access this post, you must purchase The Dark Report.

Nichols Institute Earns ISO 9001 Certification Read More Ā»

Expect ISO 9000 To Alter Clinical Lab Management

Laboratory Management /

CEO SUMMARY: Perceptive laboratory executives and pathologists should welcome the impending arrival of ISO 9000 into the clinical laboratory industry. It promises to solve many problems of laboratory management. The diagnostics industry, responsible for manufacturing instruments and supplies used by clinical laboratories, has already embraced ISO 9000 with good results. MANY LABORATORY EXECUTIVES yawned at

To access this post, you must purchase The Dark Report.

Expect ISO 9000 To Alter Clinical Lab Management Read More Ā»

Unrealized Gains Targeted By Premierā€™s Lab Initiative

Laboratory Management /

CEO SUMMARY: In part one of this exclusive interview, Premierā€™s John Biggers described the reasons why the 1,700 hospital consortium developed a strategic services program for clinical laboratories. In this final installment, Biggers provides insight as to how the program will work and what the objectives will be. Biggersā€™ comments deserve careful reading, particularly by

To access this post, you must purchase The Dark Report.

Unrealized Gains Targeted By Premierā€™s Lab Initiative Read More Ā»

MedPartners To Divest Hospital-Based MD Unit

Pathology Trends /

CEO SUMMARY: Hospital-based pathologists are increasingly the target of buy-out offers by the emerging group of pathology based physician practice management (PPM) companies. But MedPartners decided that managing hospital-based physicians was something that was not in its best interest. What message should pathologists read into MedPartnerā€™s exit from managing hospital-based doctors? PATHOLOGISTS MAY WANT TO

To access this post, you must purchase The Dark Report.

MedPartners To Divest Hospital-Based MD Unit Read More Ā»

“July 6, 1998 Intelligence: Late Breaking Lab News”

Late Breaking Lab News /

Last week THE DARK REPORT toured the Framingham, Massachusetts laboratory of Genzyme Genetics, the diagnostic testing division of Genzyme Corporation. It is probably the largest genetics-based diagnostics laboratory organization in the United States. The companyā€™s roots are in pregnancy testing for early detection of inherited diseases and similar conditions. Thus, a necessary part of the

To access this post, you must purchase The Dark Report.

“July 6, 1998 Intelligence: Late Breaking Lab News” Read More Ā»

Facebook-f Twitter Linkedin-in

The Dark Report ā€¢ 21806 Briarcliff Dr ā€¢ Spicewood, TX 78669
Phone: 512-264-7103
Email: info@darkreport.com

Ā© 2025 The Dark Report. All rights reserved.

;